The U.S. Food and Drug Administration gave De Novo clearance to Techsomed's BioTraceIO, which leverages a computational algorithm to analyze ultrasound images captured during liver ablation treatment ...
Doctors have a new emerging weapon in the fight against cancerous tumors: ultrasound. After a five-year study by the ...
Surgery and radiofrequency ablation showed similar 5-year survival rates for small liver tumors. Both treatments had nearly identical 5-year recurrence-free survival outcomes. Patient and tumor ...
Parenchymal-sparing liver resection with microwave ablation is safe and effective for patients who have neuroendocrine tumors (NETs) and a high number of liver metastases; the treatment has no effect ...
A new study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center may help explain why certain liver tumors return quickly after thermal ablation, a widely used ...
Chicago — Surgical resection is the standard of care for small colorectal liver metastases, but the results of a phase 3 trial reported at the American Society of Clinical Oncology (ASCO) 2024 annual ...
Colorectal cancer is the second most common cancer in women and the third most common cancer in men in the UK. The liver is the most common site for metastases. Curative treatment for patients with ...
Microwave is not a word you think would be used to describe a medical procedure. But it is. Microwave ablation is a laparoscopic procedure for cancer therapy, said Dr. Zachary Senders, a ...
This section describes efficacy outcomes from the published literature that the committee considered as part of the evidence about this procedure. For more detailed information on the evidence, see ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results